People in the News: Kevin Conroy, Katherine Napier, David Thompson, and Roopwant Judge | GenomeWeb

Exact Sciences' shareholders have re-elected three members of its board of directors, including company President and CEO Kevin Conroy, as well as Katherine Napier, and David Thompson.

Napier, who has been a director since 2009, spent over two decades at Procter and Gamble, where she was a GM of the firm's North American pharmaceutical business.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Nature this week: weighting scheme increases GWAS power, and more.

Marc Tessier-Lavigne is to be the next president of Stanford University.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.